Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The RNA genome of hepatitis C virus (HCV) displays extensive sequence variation, and consequently, the virus is classified into six major genotypes. The severity of disease and response to antiviral treatment are thought to be influenced by both viral and host-related factors, including age of aquisition, duration of infection, circulating virus load, and the genotype of infecting virus Many investigators have reported that infections with HCV type 1 are associated with an increase in the likelihood of progression to hepatocellular carcinoma (1-3), and with nonresponsiveness to interferon therapy when compared to genotypes 2 or 3 (reviewed in refs. 4,5) This discovery emphasizes the need for genotyping methods in current clinical practice, in providing a predictor of the outcome of treatment, and perhaps helping to target appropriate treatment to the most relevant patient groups.

Original publication

DOI

10.1385/0-89603-521-2:199

Type

Journal article

Journal

Methods Mol Med

Publication Date

1999

Volume

19

Pages

199 - 205